Clinical trials
Lymphoma, Non-Hodgkin trials in China with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 1 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 6 |
| Recruiting | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hebei Senlang Biotechnology Inc., Ltd. | 3 |
| Bioray Laboratories | 1 |
| CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | 1 |
| Henan Cancer Hospital | 1 |
| PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 1 |
| Shanxi Bethune Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Non-Hodgkin | 8 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 |
| Multiple Myeloma | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.